Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory subm...
- Home
- News & Events
- Events
- Webinars
Webinars
-
Webinars
Riding the data wave: How pharma can navigate disruptions in open claims
Date 8 December 2025 Time 12:00 - 13:00 Location Webinar Timezone EST - America/New York -
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
Date 18 November 2025 Time 15:00 - 16:00 Location Webinar Timezone CET - Europe/Dublin -
Webinars
Beyond the bench: The advantages of GMP over USP compounding in early phase development
Date 6 November 2025 Time 11:00 - 12:00 Location Webinar Timezone ET - America/New York -
Webinars
Introducing ICON Strategic Solutions FSP Services: How This Model Supports Sponsors in Korea
Date 28 October 2025 Time 14:00 - 15:00 Location Webinar Timezone KST - Asia/Seoul -
Webinars
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
Date 22 October 2025 Time 11:00 - 12:00 Location Webinar Timezone EDT - America/New York -
Webinars
Identifying and mitigating risks in pediatric protocol development: Strategies, tools & access planning
Date 15 October 2025 Time 10:00 - 11:00 Location Webinar Timezone EDT - America/New York -
Webinars
Enhancing clinical trials in obesity by integrating clinical outcome assessment and digital health technologies
Date 7 October 2025 Time 11:00 - 12:00 Location Webinar Timezone ET - America/New York -
Webinars
ASA BIOP event: Pivotal trial design considerations for new and next generation cell and gene therapies
Date 5 September 2025 Time 11:00 - 12:00 Location Webinar Timezone EDT - America/New York -
Webinars
Network meta-analysis and its role in evidence-based decision-making
Date 9 July 2025 Time 10:00 - 11:00 Location Webinar Timezone ET - America/New York
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.